186 related articles for article (PubMed ID: 5597423)
1. [On the problem of chloroquine damage to the eye].
Böke W; Bäumer A; Müller-Limmroth W; Mludek M
Klin Monbl Augenheilkd; 1967 Nov; 151(5):617-33. PubMed ID: 5597423
[No Abstract] [Full Text] [Related]
2. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
3. Drug-induced macular disease.
Potts AM
Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(6):1054-7. PubMed ID: 5971468
[No Abstract] [Full Text] [Related]
4. Chloroquine ocular toxicity.
Bernstein HN
Surv Ophthalmol; 1967 Oct; 12(5):415-47. PubMed ID: 4980087
[No Abstract] [Full Text] [Related]
5. [The changes in the electric retinal activity during resochin treatment].
Svĕrák J; Peregrin J; Salavec M
Klin Monbl Augenheilkd; 1967 Nov; 151(5):633-40. PubMed ID: 5597424
[No Abstract] [Full Text] [Related]
6. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1966; 44(3):335-48. PubMed ID: 5953229
[No Abstract] [Full Text] [Related]
7. The prevention of drug-induced retinopathies.
Crews SJ
Trans Ophthalmol Soc U K (1962); 1966; 86():63-76. PubMed ID: 5335103
[No Abstract] [Full Text] [Related]
8. Chloroquine retinopathy: evaluation by fluorescein fundus angiography.
Kearns TP; Hollenhorst RW
Trans Am Ophthalmol Soc; 1966; 64():217-31. PubMed ID: 5964922
[No Abstract] [Full Text] [Related]
9. Chloroquine and organic changes in the eye.
Carr RE
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:36-9. PubMed ID: 5672562
[No Abstract] [Full Text] [Related]
10. On very short wavelength electroretinography. An original technique of diagnosis in infraclinical synthetic antimalarial retinopathies.
Alfieri R; Sole P
Ophthalmologica; 1969; 158 Suppl():661-8. PubMed ID: 5359763
[No Abstract] [Full Text] [Related]
11. [Ocular involvement in chloroquine therapy].
Godel V; Nemet P; Stein R
Harefuah; 1972 Jul; 83(2):60-3. PubMed ID: 5068910
[No Abstract] [Full Text] [Related]
12. [On ocular damage caused by chloroquine].
Rinaldi G; Coslovich E; Tuvo F
Minerva Med; 1971 Feb; 62(16):766-9. PubMed ID: 5313741
[No Abstract] [Full Text] [Related]
13. Electrodiagnosis in drug-induced disorders of the eye.
Adlakha D; Crews SJ; Shearer AC; Tonks EL
Trans Ophthalmol Soc U K (1962); 1967; 87():267-84. PubMed ID: 5255222
[No Abstract] [Full Text] [Related]
14. [Prognostic observation of chloroquine retinopathy].
Kikkawa T
Ganka; 1971 Jul; 13(7):726-36. PubMed ID: 5105836
[No Abstract] [Full Text] [Related]
15. Acquired color vision defects secondary to retinal drug toxicity.
Grützner P
Ophthalmologica; 1969; 158 Suppl():592-604. PubMed ID: 5307973
[No Abstract] [Full Text] [Related]
16. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
Bertrand JJ; Debeyre N; Kahn MF; Ryckewaert A
Presse Med (1893); 1968 Nov; 76(45):2139-42. PubMed ID: 5720115
[No Abstract] [Full Text] [Related]
17. [Clinical studies on eye changes during long-term chloroquine therapy].
Pambor R
Dtsch Gesundheitsw; 1968 Dec; 23(50):2383-9. PubMed ID: 5729806
[No Abstract] [Full Text] [Related]
18. Pigmentation and retinopathy due to chloroquine.
Stewart TW; Miles DW; Earnshaw ER
Acta Derm Venereol; 1968; 48(1):47-52. PubMed ID: 4174103
[No Abstract] [Full Text] [Related]
19. The early detection of chloroquine retinopathy with the Friedmann visual field analyser.
Friedmann AI
Ophthalmologica; 1969; 158 Suppl():583-91. PubMed ID: 5359757
[No Abstract] [Full Text] [Related]
20. Delayed chloroquine retinopathy.
Br Med J; 1967 Feb; 1(5535):254. PubMed ID: 6017471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
